Author

Russell Burley

Observed names: Burley J Russell, Russell J. Burley

Observed institution: Takeda (United Kingdom)

OpenAlex ID: A5014393227

Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS

2017 · Claire E. Hall, Zhi Yao, et al. · Cell Reports · 179

Luvadaxistat: A Novel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia

2023 · Rosa Fradley, Pascal Goetghebeur, et al. · Neurochemical Research · 36

Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome

2022 · Bernardino Ossola, Ali Rifat, et al. · Neuropharmacology · 30

S22. Pre-clinical Assessment of Tak-831, a Selective D-amino Acid Oxidase Inhibitor, in Animal Models of Schizophrenia

2019 · Rosa Fradley, Pascal Goetghebeur, et al. · Schizophrenia Bulletin · 6

Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators

2022 · Russell Burley, Richard C. Hewer, et al. · Bioorganic & Medicinal Chemistry Letters · 3

Multielectrode Arrays

2020 · Russell Burley, Jenna R. M. Harvey · Methods in molecular biology · 3

NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasia

2025 · Giuliano G. Stirparo, Xiao Xu, et al. · Frontiers in Neuroscience · 1

NETSseq Reveals Inflammatory and Aging Mechanisms in Distinct Cell Types Driving Cerebellar Decline in Ataxia Telangiectasia

2025 · Stirparo G Giuliano, Xu Xiao, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Correction to: Luvadaxistat: A Novel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia

2023 · Rosa Fradley, Pascal Goetghebeur, et al. · Neurochemical Research

Works count: 9

Citation count: 258

H-index: 4

I10-index: 3